- Investing Ideas
- /
- Swedish Pharmaceuticals & Biotech Fast Growing Stocks With High Insider Ownership
Swedish Pharmaceuticals & Biotech Fast Growing Stocks With High Insider Ownership
Results
12
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
12 companies
Xbrane Biopharma
Market Cap: SEK 344.1m
A biotechnology company, engages in the development, manufacture, and sale of biosimilars.
XBRANE
SEK 0.22
7D
-5.5%
1Y
-24.6%
Bonesupport Holding
Market Cap: SEK 16.7b
An orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally.
BONEX
SEK 254.20
7D
-3.6%
1Y
-0.08%
Diamyd Medical
Market Cap: SEK 1.2b
Develops precision medicine therapies for the treatment of autoimmune diabetes.
DMYD B
SEK 8.80
7D
-3.5%
1Y
-24.0%
Guard Therapeutics International
Market Cap: SEK 367.1m
A pharmaceutical company, identifies, develops, and commercializes therapies for the diagnosis and treatment of acute kidney injuries in Sweden.
GUARD
SEK 18.20
7D
12.3%
1Y
-46.2%
Devyser Diagnostics
Market Cap: SEK 1.7b
Engages in the development, manufacture, and sale of diagnostic kits and solutions for DNA testing within hereditary diseases, oncology, and post-transplantation monitoring in Sweden, rest of Europe, the Middle East, Africa, North and South America, and Asia.
DVYSR
SEK 105.20
7D
5.2%
1Y
0.7%
Klaria Pharma Holding AB (publ.)
Market Cap: SEK 61.5m
A pharmaceutical company develops and commercializes medication for migraine and cancer related pain, as well as opioid overdose and anaphylactic shock.
KLAR
SEK 0.42
7D
-49.0%
1Y
-18.6%
Egetis Therapeutics
Market Cap: SEK 1.2b
A pharmaceutical company, focuses on projects in late-stage development for the treatment of serious diseases with unmet medical needs in the orphan drug segment.
EGTX
SEK 3.40
7D
12.4%
1Y
-57.9%
SynAct Pharma
Market Cap: SEK 685.1m
A clinical stage biotechnology company, researches and develops medicines for the treatment of inflammatory diseases in Sweden.
SYNACT
SEK 13.98
7D
-22.8%
1Y
105.6%
Mendus
Market Cap: SEK 275.0m
A biopharmaceutical company, develops immunotherapies for the treatment of tumor recurrence and established tumors.
IMMU
SEK 5.28
7D
2.7%
1Y
-47.9%
Initiator Pharma
Market Cap: SEK 206.1m
A clinical stage life science company, develops drugs targeting unmet medical needs within the central and peripheral nervous system.
INIT
SEK 3.67
7D
-5.7%
1Y
-64.2%
Genovis AB (publ.)
Market Cap: SEK 1.7b
Develops and sells tools for the development of new treatment methods and diagnostics in North America, Europe, and Asia.
GENO
SEK 26.05
7D
-1.1%
1Y
-31.9%
Swedencare
Market Cap: SEK 6.4b
Develops, manufactures, markets, and sells animal healthcare products for cats, dogs, and horses in North America, Europe, and internationally.
SECARE
SEK 40.00
7D
5.5%
1Y
-32.4%